1. High DOCK1 expression identifies a distinct prognostic subgroup of pediatric acute myeloid leukemia: Results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML‐05 trial
   Masahiro Yoshitomi et al, 2024, Pediatric Blood & Cancer CrossRef
2. Combinatorial genetics reveals the Dock1-Rac2 axis as a potential target for the treatment of NPM1;Cohesin mutated AML
   Alison E. Meyer et al, 2022, Leukemia CrossRef
3. Expression analysis of hsa_circ_0020397, hsa_circ_0005986, hsa_circ_0003028, and hsa_circ_0006990 in renal cell carcinoma
   Elham Mohammadisoleimani et al, 2023, Experimental and Molecular Pathology CrossRef
4. The role of Popeye domain‐containing protein 1 (POPDC1) in the progression of the malignant phenotype
   Steven J. Tucker et al, 2022, British Journal of Pharmacology CrossRef
5. Cisplatin Polylactic Acid Nanoparticles Combined with miR-181a Alleviates the Growth, Migration and Apoptosis of PG Cells in Lung Cancer Rats
   Kangmei Zhang et al, 2023, Journal of Biomedical Nanotechnology CrossRef